Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly L McCoy

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 15, 2005
Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletionJonathan P Pearl, Jeremy Parris, Douglas A Hale, et al.
Thyroid : Official Journal of the American Thyroid Association|May 7, 2014
PAX8/PPARγ rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular the encapsulated follicular variant of papillary carcinomaMichaele J Armstrong, Huaitao Yang, Linwah Yip, et al.
The Journal of Clinical Endocrinology and Metabolism|March 16, 2012
Cost impact of molecular testing for indeterminate thyroid nodule fine-needle aspiration biopsiesLinwah Yip, Coreen Farris, Adam S Kabaker, et al.
Journal of the American College of Surgeons|July 7, 2012
Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancerKelly L McCoy, Sally E Carty, Michaele J Armstrong, et al.
Surgery|December 3, 2014
Surgeon volume and adequacy of thyroidectomy for differentiated thyroid cancerCameron D Adkisson, Gina M Howell, Kelly L McCoy, et al.
Surgery|October 9, 2024
Tumor size and molecular risk group are associated with differentiated thyroid cancer recurrenceSaba Kurtom, Jason B Liu, William R Doerfler, et al.
Cancer Cytopathology|August 14, 2012
BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinomaN Paul Ohori, Rashi Singhal, Marina N Nikiforova, et al.
Surgery|June 2, 2026
Risk factors for adrenal insufficiency after adrenalectomy for mild autonomous cortisol secretionAkanksha Aggarwal, Ali Osman Balkan, Divya Sistla, et al.
Annals of Surgical Oncology|May 20, 2011
Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancerGina M Howell, Sally E Carty, Michaele J Armstrong, et al.
Thyroid : Official Journal of the American Thyroid Association|March 28, 2023
Molecular Testing Predicts Incomplete Response to Initial Therapy in Differentiated Thyroid Carcinoma Without Lateral Neck or Distant Metastasis at Presentation: Retrospective Cohort StudyJason B Liu, Katherine A Baugh, Kimberly M Ramonell, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 15, 2005
Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletionJonathan P Pearl, Jeremy Parris, Douglas A Hale, et al.
Thyroid : Official Journal of the American Thyroid Association|May 7, 2014
PAX8/PPARγ rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular the encapsulated follicular variant of papillary carcinomaMichaele J Armstrong, Huaitao Yang, Linwah Yip, et al.
The Journal of Clinical Endocrinology and Metabolism|March 16, 2012
Cost impact of molecular testing for indeterminate thyroid nodule fine-needle aspiration biopsiesLinwah Yip, Coreen Farris, Adam S Kabaker, et al.
Journal of the American College of Surgeons|July 7, 2012
Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancerKelly L McCoy, Sally E Carty, Michaele J Armstrong, et al.
Surgery|December 3, 2014
Surgeon volume and adequacy of thyroidectomy for differentiated thyroid cancerCameron D Adkisson, Gina M Howell, Kelly L McCoy, et al.
Surgery|October 9, 2024
Tumor size and molecular risk group are associated with differentiated thyroid cancer recurrenceSaba Kurtom, Jason B Liu, William R Doerfler, et al.
Cancer Cytopathology|August 14, 2012
BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinomaN Paul Ohori, Rashi Singhal, Marina N Nikiforova, et al.
Surgery|June 2, 2026
Risk factors for adrenal insufficiency after adrenalectomy for mild autonomous cortisol secretionAkanksha Aggarwal, Ali Osman Balkan, Divya Sistla, et al.
Annals of Surgical Oncology|May 20, 2011
Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancerGina M Howell, Sally E Carty, Michaele J Armstrong, et al.
Thyroid : Official Journal of the American Thyroid Association|March 28, 2023
Molecular Testing Predicts Incomplete Response to Initial Therapy in Differentiated Thyroid Carcinoma Without Lateral Neck or Distant Metastasis at Presentation: Retrospective Cohort StudyJason B Liu, Katherine A Baugh, Kimberly M Ramonell, et al.
Pageof 9